Options activity stands out in Ultragenyx Pharmaceutical (RARE) with 20,859 contracts traded so far today, indicating heightened near-term positioning. The note is descriptive (no catalyst, earnings, or guidance change cited), so likely impact is limited to short-term sentiment/flow rather than fundamentals.
Options activity stands out in Ultragenyx Pharmaceutical (RARE) with 20,859 contracts traded so far today, indicating heightened near-term positioning. The note is descriptive (no catalyst, earnings, or guidance change cited), so likely impact is limited to short-term sentiment/flow rather than fundamentals.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.02
Ticker Sentiment
